FIM
AMRX icon

Freedom Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Freedom Investment Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,090
Closed -$51K – 614
2020
Q3 		$51K Sell
13,090
-1,765
-12% -$7.55K 0.01% 546
2020
Q2 		$71K Sell
14,855
-1,178
-7% -$4.85K 0.01% 547
2020
Q1 		$78K Buy
16,033
+143
+0.9% +$606 0.01% 656
2019
Q4 		$77K Sell
15,890
-1,584
-9% -$5.51K 0.01% 651
2019
Q3 		$51K Sell
17,474
-2,891
-14% -$10.1K ﹤0.01% 677
2019
Q2 		$146K Sell
20,365
-2,248
-10% -$23K 0.01% 651
2019
Q1 		$320K Sell
22,613
-4,785
-17% -$63.2K 0.03% 496
2018
Q4 		$371K Sell
27,398
-1,993
-7% -$35.9K 0.03% 499
2018
Q3 		$691K Buy
29,391
+582
+2% +$12.2K 0.04% 420
2018
Q2 		$473K Buy
+28,809
New +$506K 0.03% 577

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Freedom Investment Management's AMRX Position: Q4 2020 in Review

Freedom Investment Management sold out of Amneal Pharmaceuticals (AMRX) in Q4 2020, closing a stake of 13,090 shares — an estimated $51K sold.

Freedom Investment Management first reported a position in AMRX in Q2 2018 and held it in 10 quarters. The position peaked at $691K in Q3 2018. 133 funds tracked by Wall St. Rank hold AMRX as of Q4 2020.

  • Freedom Investment Management reported no remaining Amneal Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Freedom Investment Management sold 13,090 Amneal Pharmaceuticals shares in Q4 2020, an estimated $51K.
  • Freedom Investment Management first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 10 quarters.
  • Freedom Investment Management's Amneal Pharmaceuticals position peaked at $691K in Q3 2018.
  • 133 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2020.

Based on Freedom Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.